CLLS
Price
$3.98
Change
-$0.54 (-11.95%)
Updated
Oct 17 closing price
Capitalization
474.94M
23 days until earnings call
CMVLF
Price
$5.04
Change
+$2.44 (+93.85%)
Updated
Oct 16 closing price
Capitalization
474.94M
Interact to see
Advertisement

CLLS vs CMVLF

Header iconCLLS vs CMVLF Comparison
Open Charts CLLS vs CMVLFBanner chart's image
Cellectis SA
Price$3.98
Change-$0.54 (-11.95%)
Volume$219.05K
Capitalization474.94M
Cellectis Romainville
Price$5.04
Change+$2.44 (+93.85%)
Volume$100
Capitalization474.94M
CLLS vs CMVLF Comparison Chart in %
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. CMVLF commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Hold and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (CLLS: $3.98 vs. CMVLF: $5.04)
Brand notoriety: CLLS and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 144% vs. CMVLF: 100%
Market capitalization -- CLLS: $474.94M vs. CMVLF: $474.94M
CLLS [@Biotechnology] is valued at $474.94M. CMVLF’s [@Biotechnology] market capitalization is $474.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 0 FA rating(s) are green whileCMVLF’s FA Score has 0 green FA rating(s).

  • CLLS’s FA Score: 0 green, 5 red.
  • CMVLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLLS and CMVLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 4 TA indicator(s) are bullish while CMVLF’s TA Score has 5 bullish TA indicator(s).

  • CLLS’s TA Score: 4 bullish, 4 bearish.
  • CMVLF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CMVLF is a better buy in the short-term than CLLS.

Price Growth

CLLS (@Biotechnology) experienced а -1.49% price change this week, while CMVLF (@Biotechnology) price change was +93.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

CLLS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($475M) and CMVLF($475M) have the same market capitalization . CMVLF YTD gains are higher at: 236.000 vs. CLLS (121.111). CLLS (-30.25M) and CMVLF (-30.25M) have comparable annual earnings (EBITDA) . CLLS (196M) and CMVLF (196M) have equal amount of cash in the bank . CLLS (94.8M) and CMVLF (94.8M) have identical debt. CLLS (56.3M) and CMVLF (56.3M) have equivalent revenues.
CLLSCMVLFCLLS / CMVLF
Capitalization475M475M100%
EBITDA-30.25M-30.25M100%
Gain YTD121.111236.00051%
P/E RatioN/AN/A-
Revenue56.3M56.3M100%
Total Cash196M196M100%
Total Debt94.8M94.8M100%
FUNDAMENTALS RATINGS
CLLS vs CMVLF: Fundamental Ratings
CLLS
CMVLF
OUTLOOK RATING
1..100
8537
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1975

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (34) in the Biotechnology industry is in the same range as CMVLF (38) in the null industry. This means that CLLS’s stock grew similarly to CMVLF’s over the last 12 months.

CLLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CMVLF (100) in the null industry. This means that CLLS’s stock grew similarly to CMVLF’s over the last 12 months.

CLLS's SMR Rating (98) in the Biotechnology industry is in the same range as CMVLF (98) in the null industry. This means that CLLS’s stock grew similarly to CMVLF’s over the last 12 months.

CMVLF's Price Growth Rating (34) in the null industry is in the same range as CLLS (35) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to CLLS’s over the last 12 months.

CMVLF's P/E Growth Rating (100) in the null industry is in the same range as CLLS (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLLSCMVLF
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
33%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 3 days ago
40%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
26%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEYGX37.790.25
+0.67%
American Century Equity Growth R5
YACKX25.250.11
+0.44%
AMG Yacktman I
CLTAX16.910.03
+0.18%
Catalyst/Lyons Tactical Allocation A
USEMX26.180.01
+0.04%
Victory Emerging Markets
RVPIX9.07-0.08
-0.87%
Royce Smaller-Companies Growth Instl

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-11.95%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
-1.37%
MDGL - CLLS
40%
Loosely correlated
-0.73%
PMVP - CLLS
38%
Loosely correlated
-2.78%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
-11.95%
ABCZF - CMVLF
59%
Loosely correlated
N/A
SLN - CMVLF
41%
Loosely correlated
-1.37%
ALDX - CMVLF
39%
Loosely correlated
-2.41%
CLGN - CMVLF
37%
Loosely correlated
-0.64%
More